Skip to main content
. 2023 Oct 9;203(2):235–243. doi: 10.1007/s10549-023-07129-1

Fig. 1.

Fig. 1

CONSORT diagram of study population. Cohort I: All patients registered in NKBC with stage I-III breast cancer who underwent surgery and had adequate information for IHC-subtyping. Cohort II: restricted only to patients who received neoadjuvant chemotherapy (NAC) (BcBASE 3.0, NKBC, 2008-2019).